Dow -1.07% 18015pts, Nasdaq -0.93 % 5269pts , S&P -0.93% 2151pts
| $CATB |
|
|
|
|
|
|
| Catabasis
Pharmaceuticals Inc |
|
|
|
|
| Industria:
Biotecnología |
|
|
|
|
|
| Sector:
Healthcare |
|
|
|
|
|
|
|
|
|
|
|
|
$CATB subió +41,53% a $6.39 luego de anunciar un
convenio con Sarepta Pharmaceuticals (SRPT)
 |
| $ITCI |
|
|
|
|
|
|
| Intra-Cellular
Therapies Inc |
|
|
|
|
|
| Industria:
Healthcare |
|
|
|
|
|
| Sector:
Biotechnologia |
|
|
|
|
|
|
|
|
|
|
|
|
| $ITCI bajó 63.48% a $15.35 luego de anunciar que su ensayo para el tratamiento de la
esquizofrenia |
| no alcanzo
los objetivos primarios |
|
|
|
|
| Otros Stocks: |
|
|
|
|
|
|
| $MRUS
,$AEGR , $DRNA , $BSPM , $ADHD , $MRNS , $ATNM |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
